Association between PTGS2 polymorphism and autism spectrum disorders in Korean trios

Neuroscience Research

Volumn 62, Issue 1, 2008, Pages 66-69

  Yoo, Hee Jeong ^a   Cho, In Hee ^b   Park, Mira ^c   Cho, Eunchung ^a   Cho, Soo Churl ^d   Kim, Bung Nyun ^d   Kim, Jae Won ^d   Kim, Soon Ae ^c  

^a Seoul National University Bundang Hospital   (South Korea)

^b Gachon University   (South Korea)

^c Eulji University   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Association study; Autism spectrum disorders (ASD); Cyclooxygenase 2; Transmission disequilibrium test (TDT)

Indexed keywords

CYCLOOXYGENASE 2;

AGITATION; ALLELE; ARTICLE; AUTISM; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENOTYPE; HAPLOTYPE; HUMAN; HYPERACTIVITY; KOREA; MAJOR CLINICAL STUDY; MALE; MUTATOR GENE; PATHOGENESIS; PRIORITY JOURNAL; PTGS2 GENE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL INTERACTION;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BRAIN; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 2; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; PARENTS; POLYMORPHISM, GENETIC; SOCIAL BEHAVIOR; SOCIAL BEHAVIOR DISORDERS;

EID: 48049104836     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.05.008     Document Type: Article

References (21)

1. Ashwood P., Wills S., and Van de Water J. The immune response in autism: a new frontier for autism research. J. Leukoc. Biol. 80 (2006) 1-15
2. Brune C.W., Kim S.J., Salt J., Leventhal B.L., Lord C., and Cook E.H. 5-HTTLPR genotype-specific phenotype in children and adolescents with autism. Am. J. Psychiatry 163 (2006) 2148-2156
3. Buxbaum J.D., Silverman J., Keddache M., Smith C.J., Hollander E., Ramoz N., and Reichert J.G. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol. Psychiatry 9 (2004) 144-150
4. Cheng I., Liu X., Plummer S.J., Krumroy L.M., Casey G., and Witte J.S. COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br. J. Cancer 97 (2007) 557-561
5. Cho I.H., Yoo H.J., Park M., Lee Y.S., and Kim S.A. Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res. 1139 (2007) 34-41
6. Claycomb R.J., Hewett S.J., and Hewett J.A. Hippocampal cyclooxygenase-2 (COX-2) is upregulated during pentylenetetrazole (PTZ)-induced kindling. Soc. Neurosci. (2005) Online Program No. 43310
7. Folsteinl S.E., and Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2 (2001) 943-955
8. Ibuki T., Matsumura K., Yamazaki Y., Nozaki T., Tanaka Y., and Kobayashi S. Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J. Neurochem. 86 (2003) 318-328
9. Kaufmann W.E., Worley P.F., Taylor C.V., Bremer M., and Isakson P.C. Cyclooxygenase-2 expression during rat neocortical development and in Rett syndrome. Brain Dev. 19 (1997) 25-34
10. Kim S.A., Kim J.H., Park M., Cho I.H., and Yoo H.J. Association of GABRB3 polymorphisms with autism spectrum disorders in Korean trios. Neuropsychobiology 54 (2006) 160-165
11. Kim S.A., Kim J.H., Park M., Cho I.H., and Yoo H.J. Family-based association study between GRIK2 polymorphisms and autism spectrum disorders in the Korean trios. Neurosci. Res. 58 (2007) 332-335
12. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
13. Ricceri L., Minghetti L., Moles A., Popoli P., Confaloni A., De Simone R., Piscopo P., Scattoni M.L., di Luca M., and Calamandrei G. Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp. Neurol. 189 (2004) 162-172
14. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamron B., Yoon S., Krasnitz A., Kendall J., Leotta A., Pai D., Zhang R., Lee Y.H., Hicks J., Spence S.J., Lee A.T., Puura K., Lehtimaki T., Ledbetter D., Gregersen P.K., Bregman J., Sutcliffe J.S., Jobanputra V., Chung W., Warburton D., King M.C., Skuse D., Geshwind D.H., Gilliam T.C., Ye K., and Wigler M. Strong association of de novo copy number mutations with autism. Science 316 5823 (2007) 445-449
15. Wei J., and Hemmings G.P. A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 413-415
16. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., Platt O.S., Ruderfer D.W., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.L., and Daly M.J. Autism consortium. Association between microdeletion and microduplication at 16p11 2 and autism. N. Eng. J. Med. 358 7 (2008) 667-675
17. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
18. Yermakova A.V., and O'Banion M.K. Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease. Neurobiol. Aging 22 (2001) 823-836
19. Yoo, H.J., 2007. Korean version of Autism Diagnostic Interview-Revised (ADI-R). Hakji-sa, Seoul.
20. Yoo, H.J., Kwak Y., in press. Korean Version of Autism Diagnostic Observation Schedule (ADOS). Hakji-sa, Seoul.
21. Zhang X., Miao X., Tan W., Ning B., Liu Z., Hong Y., Song W., Guo Y., Zhang X., Shen Y., Qiang B., Kadlubar F.F., and Lin D. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129 (2005) 565-576